Proton pump inhibitors associated with severe COVID-19 among two-dose but not three-dose vaccine recipients.
Ka Shing CheungVincent K C YanXuxiao YeIvan F N HungEsther W ChanWai-Keung LeungPublished in: Journal of gastroenterology and hepatology (2024)
Although PPI use was associated with a higher COVID-19 risk, severe infection was limited to two-dose but not three-dose vaccine recipients.
Keyphrases